Yet, PrEP use is lowest among Black Americans ( Jenness et al., 2018 Smith, 2018) nearly six times as many White individuals than Black individuals have been prescribed PrEP. Of the 1.1 million persons estimated to be candidates for PrEP, 45% are Black ( Smith, 2018). In 2012, the Food and Drug Administration approved the use of Truvada for HIV pre-exposure prophylaxis (PrEP), yet there are disparities in PrEP use that reflect those seen in HIV incidence. Furthermore, despite having fewer sex partners and HIV-related risk behaviors than their White counterparts ( Friedman, Cooper and Osborne, 2009), half of Black GBM are projected to acquire HIV in their lifetime, compared to 25% of Latino GBM and just 9% of White GBM ( Hess et al., 2017). Between 20, HIV diagnoses among GBM remained stable overall, yet diagnoses among GBM aged 25 to 34 increased 30% ( Centers for Disease Control and prevention, 2018). ![]() In the United States, reducing new HIV infections will require a prioritization of HIV prevention among young Black gay, bisexual, or other men who have sex with men (GBM), a population that continues to carry a disproportionate burden of HIV ( Centers for Disease Control and Prevention, 2016).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |